Coronavirus

Brazil announces efficacy of China's CoronaVac vaccine

Chinese COVID-19 vaccine found 79% effective in late stage trial

Beijing: A Chinese inactivated vaccine shows 79.34 percent efficacy against COVID-19, according to the interim results of the phase-3 clinical trials unveiled by its developer Wednesday. The inactivated vaccine has been developed by the Beijing Biological Products Institute Co., Ltd. under the China National Biotec...

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Archives

Editorial